News

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...
Wall Street held near its record heights on Monday, ahead of a week likely to be dominated by updates from the head of the ...
Novo Nordisk (NYSE:NVO) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On August 15, Novo ...
The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share ...
Dow Jones Top Company Headlines at 9 PM ET: SoftBank Invests $2 Billion in Intel as U.S. Considers Taking 10% Stake in Chip Maker | BHP ... SoftBank Invests $2 Billion in Intel as U.S. Considers ...
The detention facility operator named Patrick Swindle as its next chief executive officer, succeeding long-time executive Damon Hininger, who will continue at the company under a transition agreement.
Worldwide, 3·9 million individuals have kidney failure requiring maintenance dialysis.1,2 Considerable resources—more than 7% ...
I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...
U.S. District Judge Karen Marston, of the Eastern District of Pennsylvania, allowed some misrepresentation claims to go ...